245 related articles for article (PubMed ID: 30926242)
1. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
[TBL] [Abstract][Full Text] [Related]
2. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
[TBL] [Abstract][Full Text] [Related]
3. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition.
Denuc A; Bosch-Comas A; Gonzàlez-Duarte R; Marfany G
PLoS One; 2009; 4(5):e5571. PubMed ID: 19440361
[TBL] [Abstract][Full Text] [Related]
4. A quaternary tetramer assembly inhibits the deubiquitinating activity of USP25.
Liu B; Sureda-Gómez M; Zhen Y; Amador V; Reverter D
Nat Commun; 2018 Nov; 9(1):4973. PubMed ID: 30478318
[TBL] [Abstract][Full Text] [Related]
5. Regulation of USP28 deubiquitinating activity by SUMO conjugation.
Zhen Y; Knobel PA; Stracker TH; Reverter D
J Biol Chem; 2014 Dec; 289(50):34838-50. PubMed ID: 25359778
[TBL] [Abstract][Full Text] [Related]
6. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
[TBL] [Abstract][Full Text] [Related]
8. Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25.
Valero R; Bayés M; Francisca Sánchez-Font M; González-Angulo O; Gonzàlez-Duarte R; Marfany G
Genome Biol; 2001; 2(10):RESEARCH0043. PubMed ID: 11597335
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25.
Zhong B; Liu X; Wang X; Chang SH; Liu X; Wang A; Reynolds JM; Dong C
Nat Immunol; 2012 Nov; 13(11):1110-7. PubMed ID: 23042150
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
[TBL] [Abstract][Full Text] [Related]
11. Tandem UIMs confer Lys48 ubiquitin chain substrate preference to deubiquitinase USP25.
Kawaguchi K; Uo K; Tanaka T; Komada M
Sci Rep; 2017 Mar; 7():45037. PubMed ID: 28327663
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Investigations of the N-Terminal Ubiquitin Binding Region of Usp25.
Yang Y; Shi L; Ding Y; Shi Y; Hu HY; Wen Y; Zhang N
Biophys J; 2017 May; 112(10):2099-2108. PubMed ID: 28538147
[TBL] [Abstract][Full Text] [Related]
13. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage.
Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N
Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944
[TBL] [Abstract][Full Text] [Related]
14. ¹H, ¹³C and ¹⁵N backbone and side-chain resonance assignments of the N-terminal ubiquitin-binding domains of USP25.
Shi L; Wen Y; Zhang N
Biomol NMR Assign; 2014 Oct; 8(2):255-8. PubMed ID: 23754700
[TBL] [Abstract][Full Text] [Related]
15. ¹H, ¹³C and ¹⁵N backbone and side-chain resonance assignments of the N-terminal ubiquitin-binding domains of the human deubiquitinase Usp28.
Wen Y; Cui R; Zhang H; Zhang N
Biomol NMR Assign; 2014 Oct; 8(2):251-4. PubMed ID: 23754699
[TBL] [Abstract][Full Text] [Related]
16. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization.
Fernández-Montalván A; Bouwmeester T; Joberty G; Mader R; Mahnke M; Pierrat B; Schlaeppi JM; Worpenberg S; Gerhartz B
FEBS J; 2007 Aug; 274(16):4256-70. PubMed ID: 17651432
[TBL] [Abstract][Full Text] [Related]
18. MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes.
Abdul Rehman SA; Kristariyanto YA; Choi SY; Nkosi PJ; Weidlich S; Labib K; Hofmann K; Kulathu Y
Mol Cell; 2016 Jul; 63(1):146-55. PubMed ID: 27292798
[TBL] [Abstract][Full Text] [Related]
19. USP25 Regulates EGFR Fate by Modulating EGF-Induced Ubiquitylation Dynamics.
Niño CA; Wollscheid N; Giangreco G; Maspero E; Polo S
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202887
[TBL] [Abstract][Full Text] [Related]
20. Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation.
Rougé L; Bainbridge TW; Kwok M; Tong R; Di Lello P; Wertz IE; Maurer T; Ernst JA; Murray J
Structure; 2016 Aug; 24(8):1335-1345. PubMed ID: 27452404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
